Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 410K | $4.1M | $10.00 | Jun 16, 2021 | Direct |
Stoke Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Restricted Stock Units | 40K | $631K | $15.78 | Mar 27, 2024 | Direct |
Stoke Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 2.49K | $31.5K | $12.68 | Nov 1, 2024 | Direct |
Stoke Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 10K | Nov 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STOK | Stoke Therapeutics, Inc. | Nov 1, 2024 | 3 | -$121K | 4 | Nov 5, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Oct 1, 2024 | 3 | -$115K | 4 | Oct 2, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Sep 3, 2024 | 4 | -$143K | 4 | Sep 5, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Aug 1, 2024 | 3 | -$140K | 4 | Aug 5, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Jul 1, 2024 | 3 | -$131K | 4 | Jul 3, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Jun 3, 2024 | 4 | -$146K | 4 | Jun 5, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | May 1, 2024 | 3 | -$108K | 4 | May 3, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Apr 1, 2024 | 3 | -$124K | 4 | Apr 3, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Mar 27, 2024 | 2 | $0 | 4 | Jun 7, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2024 | 3 | -$25.1K | 4 | Mar 19, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Mar 1, 2024 | 3 | -$74.2K | 4 | Mar 5, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Feb 1, 2024 | 1 | -$48K | 4 | Feb 5, 2024 | CHIEF MEDICAL OFFICER |
STOK | Stoke Therapeutics, Inc. | Jan 2, 2024 | 1 | -$57.4K | 4 | Jan 4, 2024 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Dec 1, 2023 | 4 | $0 | 4 | Dec 5, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Jul 3, 2023 | 1 | -$159K | 4 | Jul 6, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Jun 1, 2023 | 1 | -$167K | 4 | Jun 5, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | May 4, 2023 | 1 | -$6.53K | 4 | May 8, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | May 1, 2023 | 3 | -$555K | 4 | May 3, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2023 | 2 | $0 | 4 | Mar 17, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Feb 3, 2023 | 2 | -$130K | 4 | Feb 7, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Jan 31, 2023 | 3 | -$61.8K | 4 | Feb 2, 2023 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Dec 7, 2022 | 1 | $0 | 4 | Dec 9, 2022 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Mar 15, 2022 | 1 | $0 | 4 | Mar 17, 2022 | Chief Medical Officer |
STOK | Stoke Therapeutics, Inc. | Jul 13, 2021 | 2 | -$1.41M | 4 | Jul 15, 2021 | Chief Medical Officer |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | 10%+ Owner |